BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31281503)

  • 1. Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression.
    Zhuang H; Qiang Z; Shao X; Wang H; Dang Y; Wang Z; Wu F; Wei W; Li Y
    Theranostics; 2019; 9(12):3639-3652. PubMed ID: 31281503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration.
    Su L; Yang K; Li S; Liu C; Han J; Zhang Y; Xu G
    Oncol Rep; 2018 Oct; 40(4):2233-2241. PubMed ID: 30066900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-promoting properties of enolase-phosphatase 1 in breast cancer via activating the NF-κB signaling pathway.
    Bu Y; Hao J; He J; Li X; Liu Y; Ma L
    Mol Biol Rep; 2023 Feb; 50(2):993-1004. PubMed ID: 36378417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.
    Li Y; Zhuang H; Zhang X; Li Y; Liu Y; Yi X; Qin G; Wei W; Chen R
    Mol Cell Proteomics; 2018 Apr; 17(4):607-618. PubMed ID: 29371291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enolase-phosphatase 1 acts as an oncogenic driver in glioma.
    Wang B; Xu X; Liu X; Wang D; Zhuang H; He X; Han T; Hong J
    J Cell Physiol; 2021 Feb; 236(2):1184-1194. PubMed ID: 32654229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
    J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
    Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
    Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
    Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
    Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress.
    Hu C; Xin Z; Sun X; Hu Y; Zhang C; Yan R; Wang Y; Lu M; Huang J; Du X; Xing B; Liu X
    J Exp Clin Cancer Res; 2023 May; 42(1):108. PubMed ID: 37122003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.